Cannabis company Tilray shares jump 11% after announcing deal with Swiss drugmaker Novartis

  • 📰 CNBC
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 72%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

The marijuana company would work with Novartis' generic drug business Sandoz, and supply non-smokable and non-combustible medical cannabis products where it is legally allowed.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 12. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

Where are your constant market updates like you provide on down days?

Cannabis King of Quebec: HEXO uplisting to NYSE soon. JV with Coors.. Better buy than Tilray hype

All I can say is L.M.F.A.O. 275-75. Yay 10% Hahahahhaahahahahhhahhah

Tilray = use extreme caution. Stock is very unstable. There's better ones out there. Just sayin.

THATs A BUY❗

When will they reach a new high?

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Cannabis company Aleafia to buy Emblem for 27% premium, in a C$173.2 million deal
ソース: MarketWatch - 🏆 3. / 97 続きを読む »

A tobacco giant hashes out a deal with a cannabis companyFaced with declining smoking rates, Altria moves into the weed business Rich Go on And switch to other medical conditions. Sorry but science is clear that cannabis is a problem as well. And then what?
ソース: TheEconomist - 🏆 6. / 92 続きを読む »

Brewer AB InBev partners with Tilray to tap cannabis drink marketAnheuser-Busch InBev , the world's largest brewer, and Canadian pot produce... 'The destination of the river is the sea! ' Meanwhile jails are still full of cannabis smokers who can't afford bail and often lose their jobs, but now there's BIG money to be made.Screw y'all!
ソース: Reuters - 🏆 2. / 97 続きを読む »